The vast majority of the breakthrough infections were mild, <-bsp-person state="{"_id":"0000017b-c0f2-d34b-a5fb-effb070f0000","_type":"00000160-6f41-dae1-adf0-6ff519590003"}">Glenda Gray-bsp-person>, co-leader of the study known as Sisonke, said in an interview, citing unpublished data from the trial, which had earlier shown the shot’s effectiveness against severe illness.
Like all Covid vaccines, J&J’s was intended and tested for its ability to prevent Covid hospitalizations and deaths. Even so, the frequency of breakthrough infections ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.